News
In a new study published in Cancer Immunology Research, scientists at the Icahn School of Medicine at Mount Sinai have ...
Combining duvelisib and romidepsin may provide a path to stem cell transplant for patients with relapsed or refractory peripheral and cutaneous T-cell lymphomas. Researchers from Somerville, ...
The efficacy of CAR-T cells in ablating solid tumors is significantly impeded by the densely packed tumor extracellular matrix (ECM). This physical ...
A team of researchers from the Changchun Institute of Applied Chemistry has developed a nanogel-based strategy to enhance the ...
In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...
Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...
A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...
A University of Florida study shows an mRNA vaccine combined with immunotherapy drugs significantly boosts the immune systems ability to fight cancer in mice, opening the door for a universal cancer ...
Intratumoral microbiota—the microbial populations residing within solid tumors—have emerged as pivotal components of the tumor microenvironment (TME ...
Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology, along with Prof. GONG Ningqiang from the University of Science and Technology of China, has developed a biomimetic ...
A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...
Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results